12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines under the PBS thanks to the Australian Government.

Selumetinib (Koselugo) will list for the first time to treat symptomatic, inoperable benign nerve tumours in children two years old and over with neurofibromatosis type 1.

Read Minister for Health press release